Hesitancy on the Front Line: The Barriers among Primary Healthcare Workers in Bali for Immunizing Children in Special Populations
Keywords:
immunization, special populations, primary health care, vaccine hesitancy, health equityAbstract
Background: Primary healthcare workers are central to national immunization efforts, yet they face significant challenges in caring for children with special health needs. Clinical hesitancy among front-line workers causes missed opportunities for vulnerable children. This study examines perceptual, competency, and systemic barriers faced by primary healthcare workers in Bali in immunizing children in special cases populations, defined as those needing health services beyond routine care due to underlying conditions. Methods: A qualitative case study was conducted in Denpasar City and Badung District, Bali Province (September 2024 - March 2025). Data were collected through in-depth interviews and Focus Group Discussions with 36 stakeholders, following COREQ guidelines. Thematic analysis was performed using NVivo 12 1. Results: The study reveals that vaccine hesitancy among primary care staff is driven by systemic barriers rather than anti-vaccine sentiment. A critical lack of specific Standard Operating Procedures forces staff into a rigid “zero-risk” bias, causing unnecessary delays for minor ailments. To mitigate liability in the absence of legal protection, staff adopt defensive practices, such as refusing action without written authorization from specialists. This bureaucratic hurdle creates a “referral trap” that fragments care and imposes financial burdens on families, thereby exacerbating health inequities. Provider hesitancy reinforces the misconception that vulnerable children are too fragile for vaccination, validating parents’ “never healthy paradigm”. Conclusion: Hesitancy in primary care stems from insufficient legal protection and guidance. To break this cycle, urgent development of "legally protective" SOPs and consultation pathways is needed to empower frontline workers and avoid excluding vulnerable children.
References
[1] Orenstein WA, Ahmed R. Simply put: Vaccination saves lives. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):4031-3. DOI: https://doi.org/10.1073/pnas.1704507114
[2] World Health Organization [Internet]. Geneva: World Health Organization; c2020. Immunization Agenda 2030: A Global Strategy to Leave No One Behind; [cited 2025 Nov 16]. Available from: https://www.who.int/publications/m/item/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind
[3] Li M, Ji C, Zeng Y, Yao D, Wang X, Shao J. Reasons for the delayed vaccination, recommendations, and safety of vaccination in children with congenital heart disease in Zhejiang, China. Hum Vaccin Immunother. 2021;17(7):2065-71. DOI: https://doi.org/10.1080/21645515.2020.1852865
[4] Liu Y, Dang Y, Wang L, Huang Y. Bridging the vaccine gap: overcoming barriers for special healthcare needs children in China. Lancet Reg Health West Pac. 2025 Aug;61:101644. DOI: https://doi.org/10.1016/j.lanwpc.2025.101644
[5] Pittet LF, Posfay-Barbe KM, Ritz N. Vaccination of immunocompromised children: an overview for physicians. Eur J Pediatr. 2021 Jun;180(6):2035-47. DOI: https://doi.org/10.1007/s00431-021-03997-1
[6] Feldman AG, Curtis DJ, Moore SL, Kempe A. Under-immunization of pediatric transplant recipients: a call to action for the pediatric community. Pediatr Res. 2020 Feb;87(2):277-81. DOI: https://doi.org/10.1038/s41390-019-0597-4
[7] Musuka G, Cuadros DF, Miller FD, Mukandavire Z, Dhliwayo T, Iradukunda PG, et al. Immunization Coverage, Equity, and Access for Children with Disabilities: A Scoping Review of Challenges, Strategies, and Lessons Learned to Reduce the Number of Zero-Dose Children. Vaccines (Basel). 2023 Jan 23;11(2):241. DOI: https://doi.org/10.3390/vaccines11020241
[8] Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tahun 2017 tentang Penyelenggaraan Imunisasi. Jakarta: Kementerian Kesehatan RI; 2017.
[9] Freitas CAM, Vilasbôas ALQ, Prado NMBL. Strategies and challenges for immunisation of children under 5 years in primary health care in different countries: a scoping review. BMC Public Health. 2023 Nov 16;23(1):2260. DOI: https://doi.org/10.1186/s12889-023-17154-8
[10] Conrado DDS, Drumond SPDC, Nascimento AID, Ajalla MEA, Santos-Pinto CDB, Oliveira EF. Vaccine hesitancy among primary care health workers in Campo Grande, after the COVID-19 pandemic. Epidemiol Serv Saude. 2023;32(2):e2022479. DOI: https://doi.org/10.1590/S1679-49742023000200007
[11] Kaur M, Coppeta L, Olesen OF. Vaccine Hesitancy among Healthcare Workers in Europe: A Systematic Review. Vaccines (Basel). 2023 Nov 17;11(11):1756. DOI: https://doi.org/10.3390/vaccines11111756
[12] Hanifah N, Herdiana I, Ardi R. Determinants of Vaccine Hesitancy in Indonesia: A Scoping Review. Makara Hubs-Asia. 2021;25(1):3-11. DOI: https://doi.org/10.7454/hubs.asia.1050520
[13] Jusril H, Rachmi CN, Amin MR, Dynes M, Sitohang V, Untung ASB, et al. Factors affecting vaccination demand in Indonesia: a secondary analysis and multimethods national assessment. BMJ Open. 2022 Aug 11;12(8):e057395. DOI: https://doi.org/10.1136/bmjopen-2021-057395
[14] Chowdhury A, Shil NC. Thinking ‘Qualitative’ Through a Case Study: Homework for a Researcher. Am J Qual Res. 2021;5(2):190-210. DOI: https://doi.org/10.29333/ajqr/11295
[15] Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh A. The case study approach. BMC Med Res Methodol. 2011 Jun 27;11:100. DOI: https://doi.org/10.1186/1471-2288-11-100
[16] Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349-57. DOI: https://doi.org/10.1093/intqhc/mzm042
[17] Memon MA, Thurasamy R, Ting H, Cheah JH. Purposive sampling: a review and guidelines for quantitative research. J Appl Struct Equ Model. 2025 Jan;9(1):1-23. DOI: https://doi.org/10.47263/JASEM.9(1)01
[18] Nowell LS, Norris JM, White DE, Moules NJ. Thematic Analysis: Striving to Meet the Trustworthiness Criteria. Int J Qual Methods. 2017;16(1):160940691773384. DOI: https://doi.org/10.1177/1609406917733847
[19] Jnanathapaswi SG. Thematic Analysis & Coding: An Overview of the Qualitative Paradigm [Internet]. ResearchGate; 2021 [cited 2025 Dec 16]. Available from: https://www.researchgate.net/publication/356924218
[20] Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999 Feb 20;318(7182):527-30. DOI: https://doi.org/10.1136/bmj.318.7182.527
[21] O’Leary ST, Opel DJ, Cataldi JR, Hackell JM; Committee on Infectious Diseases; Committee on Practice and Ambulatory Medicine. Strategies for Improving Vaccine Communication and Uptake. Pediatrics. 2024 Mar 1;153(3):e2023065039. DOI: https://doi.org/10.1542/peds.2023-065039
[22] Sibson K, Shrontz A, Jones J, Hooks O, Gerges M, Forbes J, et al. Successful Interventions to Improve Pediatric Vaccine Uptake in Hesitant Cohorts: A Scoping Review. Cureus. 2023 May 19;15(5):e39255. DOI: https://doi.org/10.7759/cureus.39255
[23] Sekhar MS, Vyas N. Defensive medicine: A bane to healthcare. Ann Med Health Sci Res. 2013 Apr;3(2):295-6. DOI: https://doi.org/10.4103/2141-9248.113688
[24] Al Saad AJ, Alhassan GM, Albedaiwi MS, Alqattan FF, Alessa FA, Alabdulmohsen HW. Acceptance of COVID-19 vaccination among parents of children with autism and other neurodevelopmental disorders in Saudi Arabia: a cross-sectional study. BMC Public Health. 2023 Dec 1;23(1):2386. DOI: https://doi.org/10.1186/s12889-023-17282-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Desak Putu Yuli Kurniati, Komang Ayu Kartika Sari, Ketut Dewi Kumara Wati, Ketut Ariawati, I Made Darma Yuda

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles in Primary Care Science and Practice (PCSP) are published as open access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This license permits non-commercial use, distribution, and reproduction in any medium freely, provided the original work is properly cited. Authors do not require additional permission from PCSP to reuse tables or figures from their own articles published in this journal for scientific or educational purposes.

